Plus Therapeutics Q2 2024 Adj EPS $(0.71) Misses $(0.53) Estimate
Author: Benzinga Newsdesk | August 14, 2024 04:45pm
Plus Therapeutics (NASDAQ:PSTV) reported quarterly losses of $(0.71) per share which missed the analyst consensus estimate of $(0.53) by 33.96 percent.